Feedback / Questions
Fablyn (lasofoxifene) - Pfizer, Ligand, Sermonix
Faslodex (fulvestrant) - AstraZeneca
OncoBEAM - Sysmex Inostics, Bayer
http://www.globenewswire.com/news-release/2019/09/23/1919274/0/en/Sermonix-Doses-First-Patient-in-Phase-2-Clinical-Trial-of-Lasofoxifene-for-Targeted-Precision-Medicine-Treatment-of-Women-With-ESR1-Mutations-in-Metastatic-Breast-Cancer.html
Sep 23, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next